{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:12:38Z","timestamp":1790460758022,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s43032-022-00901-6","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:05:30Z","timestamp":1648742730000},"page":"111-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Rheumatic Diseases in Reproductive Age\u2014the Possibilities and the Risks"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3438-0764","authenticated-orcid":false,"given":"Bogna","family":"Grygiel-G\u00f3rniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Masiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana Candace","family":"Nevaneeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Mary","family":"Jojy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"issue":"2","key":"901_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.rdc.2016.12.004","volume":"43","author":"PHP de Jong","year":"2017","unstructured":"de Jong PHP, Dolhain RJEM. Fertility, pregnancy, and lactation in rheumatoid arthritis. Rheum Dis Clin N Am. 2017;43(2):227\u201337. https:\/\/doi.org\/10.1016\/j.rdc.2016.12.004.","journal-title":"Rheum Dis Clin N Am."},{"issue":"6","key":"901_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/1744666X.2019.1606714","volume":"15","author":"C Selmi","year":"2019","unstructured":"Selmi C, Gershwin ME. Sex and autoimmunity: proposed mechanisms of disease onset and severity. Expert Rev Clin Immunol. 2019;15(6):607\u201315. https:\/\/doi.org\/10.1080\/1744666X.2019.1606714.","journal-title":"Expert Rev Clin Immunol."},{"issue":"4","key":"901_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529\u201356. https:\/\/doi.org\/10.1002\/art.41191.","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"901_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476\u201385. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770.","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"901_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.semarthrit.2020.03.006","volume":"50","author":"C Raine","year":"2020","unstructured":"Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: a systematic review. Semin Arthritis Rheum. 2020;50(6):1357\u201369. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.006.","journal-title":"Semin Arthritis Rheum."},{"key":"901_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7812\/TPP\/16-047","volume":"21","author":"S Gupta","year":"2017","unstructured":"Gupta S, Gupta N. Sj\u00f6gren syndrome and pregnancy: a literature review. Perm J. 2017;21:16\u2013047. https:\/\/doi.org\/10.7812\/TPP\/16-047.","journal-title":"Perm J."},{"issue":"2","key":"901_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00403-016-1622-2","volume":"308","author":"E Cozzani","year":"2016","unstructured":"Cozzani E, Agnoletti AF, Pappalardo F, Schiavetti I, Torino A, Parodi A. The high incidence of anti-Ro\/SSA and anti-p200 antibodies in female patients with connective tissue diseases confirms the importance of screening for congenital heart block-associated autoantibodies during pregnancy. Arch Dermatol Res. 2016;308(2):139\u201343. https:\/\/doi.org\/10.1007\/s00403-016-1622-2.","journal-title":"Arch Dermatol Res."},{"issue":"7","key":"901_CR8","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1093\/rheumatology\/keaa782","volume":"60","author":"F Motta","year":"2021","unstructured":"Motta F, Codullo V, Ramoni V, Cesari S, Ferrario G, Fiandrino G, Beneventi F, Rampello S, Johnsson H, Montecucco C, Graham GJ. Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis. Rheumatology (Oxford). 2021;60(7):3307\u201316. https:\/\/doi.org\/10.1093\/rheumatology\/keaa782.","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"901_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/aogs.13296","volume":"97","author":"M Kamper-J\u00f8rgensen","year":"2018","unstructured":"Kamper-J\u00f8rgensen M, Gammill HS, Nelson JL. Preeclampsia and scleroderma: a prospective nationwide analysis. Acta Obstet Gynecol Scand. 2018;97(5):587\u201390. https:\/\/doi.org\/10.1111\/aogs.13296.","journal-title":"Acta Obstet Gynecol Scand."},{"key":"901_CR10","doi-asserted-by":"publisher","unstructured":"Chighizola CB Lonati PA, Trespidi L, Meroni PL, Tedesco F (2020) The complement system in the pathophysiology of pregnancy and in systemic autoimmune rheumatic diseases during pregnancy. Front Immunol. 11. doi:https:\/\/doi.org\/10.3389\/fimmu.2020.02084.","DOI":"10.3389\/fimmu.2020.02084"},{"issue":"2","key":"901_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.rdc.2016.12.008","volume":"43","author":"MC Soh","year":"2017","unstructured":"Soh MC, Nelson-Piercy C. Biomarkers for adverse pregnancy outcomes in rheumatic diseases. Rheum Dis Clin N Am. 2017;43(2):201\u201314. https:\/\/doi.org\/10.1016\/j.rdc.2016.12.008.","journal-title":"Rheum Dis Clin N Am."},{"issue":"1","key":"901_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/1744666X.2019.1541739","volume":"15","author":"GGM Balbi","year":"2019","unstructured":"Balbi GGM, Domingues V, Balbi GGM, De Jes\u00fas GR, Levy RA. Use of synthetic and biologic DMARDs during pregnancy. Expert Rev Clin Immunol. 2019;15(1):27\u201339. https:\/\/doi.org\/10.1080\/1744666X.2019.1541739.","journal-title":"Expert Rev Clin Immunol."},{"issue":"12","key":"901_CR13","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1007\/s10067-020-05173-6","volume":"39","author":"Y El Miedany","year":"2020","unstructured":"El Miedany Y, Palmer D. Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy. Clin Rheumatol. 2020;39(12):3593\u2013601. https:\/\/doi.org\/10.1007\/s10067-020-05173-6.","journal-title":"Clin Rheumatol."},{"issue":"3","key":"901_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/RHU.0000000000001184","volume":"27","author":"E Ingram","year":"2021","unstructured":"Ingram E, Claus L, Kolfenbach J, Wright G, Borgelt LM. Contraceptive use in women of childbearing ability with rheumatoid arthritis. JCR J Clin Rheumatol. 2021;27(3):97\u2013101. https:\/\/doi.org\/10.1097\/RHU.0000000000001184.","journal-title":"JCR J Clin Rheumatol."},{"issue":"9","key":"901_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/14740338.2019.1636964","volume":"18","author":"V Vanni","year":"2019","unstructured":"Vanni V, De Lorenzo R, Privitera L, Canti V, Vigan\u00f2 P, Rovere-Querini P. Safety of fertility treatments in women with systemic autoimmune diseases (SADs). Expert Opin Drug Saf. 2019;18(9):841\u201352. https:\/\/doi.org\/10.1080\/14740338.2019.1636964.","journal-title":"Expert Opin Drug Saf."},{"key":"901_CR16","doi-asserted-by":"crossref","unstructured":"Vagelli R Tani C, Mosca M. Pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome: practical guide from EULAR. Pol Arch Intern Med. Published online January 25, 2017. doi:10.20452\/pamw.3906.","DOI":"10.20452\/pamw.3906"},{"key":"901_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.09.004","volume":"64","author":"BermasBL.","year":"2020","unstructured":"BermasBL. Paternal safety of anti-rheumatic medications. Best Pract Res Clin Obstet Gynaecol. 2020;64:77\u201384. https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.09.004.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"11","key":"901_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1080\/14656566.2016.1197204","volume":"17","author":"M Gerosa","year":"2016","unstructured":"Gerosa M, Schioppo T, Meroni PL. Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert Opin Pharmacother. 2016;17(11):1539\u201347. https:\/\/doi.org\/10.1080\/14656566.2016.1197204.","journal-title":"Expert Opin Pharmacother."},{"issue":"1","key":"901_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11845-018-1829-7","volume":"188","author":"MurrayKE.","year":"2019","unstructured":"MurrayKE. Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines. Ir J Med Sci. 2019;188(1):169\u201372. https:\/\/doi.org\/10.1007\/s11845-018-1829-7.","journal-title":"Ir J Med Sci"},{"issue":"2","key":"901_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41584-019-0351-2","volume":"16","author":"F F\u00f6rger","year":"2020","unstructured":"F\u00f6rger F, Villiger PM. Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity. Nat Rev Rheumatol. 2020;16(2):113\u201322. https:\/\/doi.org\/10.1038\/s41584-019-0351-2.","journal-title":"Nat Rev Rheumatol."},{"key":"901_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fmed.2017.00241","volume":"4","author":"KR Reiding","year":"2018","unstructured":"Reiding KR, Vreeker GCM, Bondt A, Bladergroen MR, Hazes JMW, van der Burgt YEM, et al. Serum protein N-glycosylation changes with rheumatoid arthritis disease activity during and after pregnancy. Front Med. 2018;4:241. https:\/\/doi.org\/10.3389\/fmed.2017.00241.","journal-title":"Front Med."},{"issue":"9","key":"901_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/acr.23143","volume":"69","author":"H Ince-Askan","year":"2017","unstructured":"Ince-Askan H, Hazes JMW, Dolhain RJEM. Identifying clinical factors associated with low disease activity and remission of rheumatoid arthritis during pregnancy: RA and pregnancy. Arthritis Care Res. 2017;69(9):1297\u2013303. https:\/\/doi.org\/10.1002\/acr.23143.","journal-title":"Arthritis Care Res."},{"key":"901_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bpobgyn.2019.09.005","volume":"64","author":"EA Littlejohn","year":"2020","unstructured":"Littlejohn EA. Pregnancy and rheumatoid arthritis. Best Pract Res Clin Obstet Gynaecol. 2020;64:52\u20138. https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.09.005.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"2","key":"901_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semarthrit.2019.03.011","volume":"49","author":"S Kishore","year":"2019","unstructured":"Kishore S, Mittal V, Majithia V. Obstetric outcomes in women with rheumatoid arthritis: results from Nationwide Inpatient Sample Database 2003\u20132011. Semin Arthritis Rheum. 2019;49(2):236\u201340. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.03.011.","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"901_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejr.2019.11.001","volume":"42","author":"MA Abdulrahman","year":"2020","unstructured":"Abdulrahman MA, Elbakry SA, Samy NS, Abdelrahman RM, Samy N. Pregnancy outcome in a cohort of Egyptian women with rheumatoid arthritis. Egypt Rheumatol. 2020;42(2):83\u20137. https:\/\/doi.org\/10.1016\/j.ejr.2019.11.001.","journal-title":"Egypt Rheumatol."},{"issue":"7","key":"901_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/rheumatology\/key053","volume":"57","author":"A Zbinden","year":"2018","unstructured":"Zbinden A, van den Brandt S, \u00d8stensen M, Villiger PM, F\u00f6rger F. Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology. 2018;57(7):1235\u201342. https:\/\/doi.org\/10.1093\/rheumatology\/key053.","journal-title":"Rheumatology."},{"issue":"3","key":"901_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/acr.23621","volume":"71","author":"N Harris","year":"2019","unstructured":"Harris N, Eudy A, Clowse M. Patient-reported disease activity and adverse pregnancy outcomes in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res. 2019;71(3):390\u20137. https:\/\/doi.org\/10.1002\/acr.23621.","journal-title":"Arthritis Care Res."},{"key":"901_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/OARRR.S87828","volume":"9","author":"C Knight","year":"2017","unstructured":"Knight C, Nelson-Piercy C. Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol Res Rev. 2017;9:37\u201353. https:\/\/doi.org\/10.2147\/OARRR.S87828.","journal-title":"Open Access Rheumatol Res Rev."},{"issue":"9","key":"901_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/1744666X.2016.1184973","volume":"12","author":"F F\u00f6rger","year":"2016","unstructured":"F\u00f6rger F, Villiger PM. Treatment of rheumatoid arthritis during pregnancy: present and future. Expert Rev Clin Immunol. 2016;12(9):937\u201344. https:\/\/doi.org\/10.1080\/1744666X.2016.1184973.","journal-title":"Expert Rev Clin Immunol."},{"issue":"7","key":"901_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-019-0240-8","volume":"15","author":"GI Yee","year":"2019","unstructured":"Yee GI, C-S, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol. 2019;15(7):391\u2013402. https:\/\/doi.org\/10.1038\/s41584-019-0240-8.","journal-title":"Nat Rev Rheumatol."},{"issue":"8","key":"901_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/acr.23730","volume":"71","author":"CJF Smith","year":"2019","unstructured":"Smith CJF, F\u00f6rger F, Bandoli G, Chambers CD. Factors associated with preterm delivery among women with rheumatoid arthritis and women with juvenile idiopathic arthritis. Arthritis Care Res. 2019;71(8):1019\u201327. https:\/\/doi.org\/10.1002\/acr.23730.","journal-title":"Arthritis Care Res."},{"issue":"7","key":"901_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"K Visser","year":"2009","unstructured":"Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E. Ann Rheum Dis. 2009 Jul;68(7):1086\u201393. https:\/\/doi.org\/10.1136\/ard.2008.094474.","journal-title":"Ann Rheum Dis."},{"key":"901_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00296-010-1643-7","volume":"31","author":"R Partlett","year":"2011","unstructured":"Partlett R, Roussou E. The treatment of rheumatoid arthritis during pregnancy. Rheumatol Int. 2011;31:445\u20139.","journal-title":"Rheumatol Int"},{"issue":"5","key":"901_CR34","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/art.27358","volume":"62","author":"CD Chambers","year":"2010","unstructured":"Chambers CD, Johnson DL, Robinson LK, Braddock SR, Xu R, Lopez-Jimenez J, et al. Organization of Teratology Information Specialists Collaborative Research Group. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum. 2010;62(5):1494\u2013503. https:\/\/doi.org\/10.1002\/art.27358.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"901_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/bjd.15802","volume":"178","author":"E Pottinger","year":"2018","unstructured":"Pottinger E, Woolf RT, Exton LS, Burden AD, Nelson-Piercy C, Smith CH. Exposure to biological therapies during conception and pregnancy: a systematic review. Br J Dermatol. 2018;178(1):95\u2013102. https:\/\/doi.org\/10.1111\/bjd.15802.","journal-title":"Br J Dermatol."},{"issue":"1","key":"901_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","volume":"151","author":"M Julsgaard","year":"2016","unstructured":"Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, Bibby BM, Uldbjerg N, Connell WR, Rosella O, Grosen A, Brown SJ, Kjeldsen J, Wildt S, Svenningsen L, Sparrow MP, Walsh A, Connor SJ, Radford-Smith G, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology. 2016;151(1):110\u20139.","journal-title":"Gastroenterology."},{"issue":"2","key":"901_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","volume":"77","author":"X Mariette","year":"2018","unstructured":"Mariette X, F\u00f6rger F, Abraham B, Flynn AD, Molt\u00f3 A, Flipo RM, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Helmer E, Wang M, Chakravarty EF. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228\u201333.","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"901_CR38","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3899\/jrheum.140189","volume":"42","author":"ME Clowse","year":"2015","unstructured":"Clowse ME, Wolf DC, F\u00f6rger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U. Pregnancy outcomes in subjects exposed to certolizumab pegol. J Rheumatol. 2015;42(12):2270\u20138.","journal-title":"J Rheumatol."},{"key":"901_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2016.11.004","volume":"76","author":"F Komaki","year":"2017","unstructured":"Komaki F, Komaki Y, Micic D, Ido A, Sakuraba A. Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u03b1 use in females with immune mediated diseases; a systematic review and meta-analysis. J Autoimmun. 2017;76:38\u201352.","journal-title":"J Autoimmun."},{"issue":"2","key":"901_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5694\/mja15.00365","volume":"204","author":"G Ngian","year":"2016","unstructured":"Ngian G, Briggs AM, Ackerman IN, Van Doornum S. Management of pregnancy in women with rheumatoid arthritis. Med J Aust. 2016;204(2):62\u20133. https:\/\/doi.org\/10.5694\/mja15.00365.","journal-title":"Med J Aust."},{"issue":"4","key":"901_CR41","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/14767058.2018.1498835","volume":"33","author":"H Aljary","year":"2020","unstructured":"Aljary H, Czuzoj-Shulman N, Spence AR, Abenhaim HA. Pregnancy outcomes in women with rheumatoid arthritis: a retrospective population-based cohort study. J Matern Fetal Neonatal Med. 2020;33(4):618\u201324. https:\/\/doi.org\/10.1080\/14767058.2018.1498835.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"9","key":"901_CR42","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s12325-020-01448-1","volume":"37","author":"Mouyis.","year":"2020","unstructured":"Mouyis. Postnatal care of woman with rheumatic diseases. Adv Ther. 2020;37(9):3723\u201331. https:\/\/doi.org\/10.1007\/s12325-020-01448-1.","journal-title":"Adv Ther."},{"issue":"10","key":"901_CR43","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1055\/s-0038-1672136","volume":"40","author":"E Naseri","year":"2018","unstructured":"Naseri E, Surita F, Borovac-Pinheiro A, Santos M, Appenzeller S, Costallat L. Systemic lupus erythematosus and pregnancy: a single-center observational study of 69 Pregnancies. Rev Bras Ginecol E Obstetr\u00edcia RBGO Gynecol Obstet. 2018;40(10):587\u201392. https:\/\/doi.org\/10.1055\/s-0038-1672136.","journal-title":"Rev Bras Ginecol E Obstetr\u00edcia RBGO Gynecol Obstet."},{"issue":"3","key":"901_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.berh.2017.09.011","volume":"31","author":"R Fischer-Betz","year":"2017","unstructured":"Fischer-Betz R, Specker C. Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2017;31(3):397\u2013414. https:\/\/doi.org\/10.1016\/j.berh.2017.09.011.","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"901_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/lupus-2016-000197","volume":"5","author":"A Antovic","year":"2018","unstructured":"Antovic A, Sennstr\u00f6m M, Bremme K, Svenungsson E. Obstetric antiphospholipid syndrome. Lupus Sci Med. 2018;5:1. https:\/\/doi.org\/10.1136\/lupus-2016-000197.","journal-title":"Lupus Sci Med"},{"issue":"6","key":"901_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/GCO.0000000000000406","volume":"29","author":"K Schreiber","year":"2017","unstructured":"Schreiber K, Radin M, Sciascia S. Current insights in obstetric antiphospholipid syndrome. Curr Opin Obstet Gynecol. 2017;29(6):397\u2013403. https:\/\/doi.org\/10.1097\/GCO.0000000000000406.","journal-title":"Curr Opin Obstet Gynecol."},{"issue":"2","key":"901_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.mayocp.2019.09.012","volume":"95","author":"JS Nusbaum","year":"2020","unstructured":"Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH, et al. Sex differences in systemic lupus erythematosus. Mayo Clin Proc. 2020;95(2):384\u201394. https:\/\/doi.org\/10.1016\/j.mayocp.2019.09.012.","journal-title":"Mayo Clin Proc."},{"issue":"10","key":"901_CR48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.annder.2015.07.015","volume":"143","author":"G Guettrot-Imbert","year":"2016","unstructured":"Guettrot-Imbert G, Morel N, Le Guern V, Plu-bureau G, Frances C, Costedoat-Chalumeau N. Pregnancy and contraception in systemic and cutaneous lupus erythematosus. Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2016;143(10):590\u2013600. https:\/\/doi.org\/10.1016\/j.annder.2015.07.015.","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie."},{"issue":"1","key":"901_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.berh.2016.05.002","volume":"30","author":"W Marder","year":"2016","unstructured":"Marder W, Littlejohn EA, Somers EC. Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol. 2016;30(1):63\u201380. https:\/\/doi.org\/10.1016\/j.berh.2016.05.002.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"5","key":"901_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ncprheum0484","volume":"3","author":"LR Sammaritano","year":"2007","unstructured":"Sammaritano LR. Therapy Insight: guidelines for selection of contraception in women with rheumatic diseases. Nat Clin Pract Rheumatol. 2007;3(5):273\u201381. https:\/\/doi.org\/10.1038\/ncprheum0484.","journal-title":"Nat Clin Pract Rheumatol."},{"key":"901_CR51","doi-asserted-by":"crossref","unstructured":"Curtis KM Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK. U.S. medical eligibility criteria for contraceptive use, 2016. . Recommendations and Reports \/ July 29, 2016 \/ 65(3);1\u2013104 .","DOI":"10.15585\/mmwr.rr6503a1"},{"issue":"4","key":"901_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1701-2163(15)30959-2","volume":"35","author":"F Nili","year":"2013","unstructured":"Nili F, McLeod L, O\u2019Connell C, Sutton E, McMillan D. Maternal and neonatal outcomes in pregnancies complicated by systemic lupus erythematosus: a population-based study. J Obstet Gynaecol Can. 2013;35(4):323\u20138. https:\/\/doi.org\/10.1016\/S1701-2163(15)30959-2.","journal-title":"J Obstet Gynaecol Can."},{"issue":"1","key":"901_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-020-2139-9","volume":"22","author":"J Davis-Porada","year":"2020","unstructured":"Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, et al. Low frequency of flares during pregnancy and postpartum in stable lupus patients. Arthritis Res Ther. 2020;22(1):52. https:\/\/doi.org\/10.1186\/s13075-020-2139-9.","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"901_CR54","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/acr.22791","volume":"68","author":"EV Arkema","year":"2016","unstructured":"Arkema EV, Palmsten K, Sj\u00f6wall C, Svenungsson E, Salmon JE, Simard JF. What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and pre-SLE. Arthritis Care Res. 2016;68(7):988\u201394. https:\/\/doi.org\/10.1002\/acr.22791.","journal-title":"Arthritis Care Res."},{"issue":"5","key":"901_CR55","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acr.21593","volume":"64","author":"MEB Clowse","year":"2012","unstructured":"Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus: family size in RA and SLE. Arthritis Care Res. 2012;64(5):668\u201374. https:\/\/doi.org\/10.1002\/acr.21593.","journal-title":"Arthritis Care Res."},{"issue":"5","key":"901_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of anti-rheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208840.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"901_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1258\/om.2011.110013","volume":"4","author":"M Singh","year":"2011","unstructured":"Singh M, Qualie J, Currie A, Howarth ES, Khare MM. Is breastfeeding safe with azathioprine? Obstet Med. 2011;4(3):104\u20137. https:\/\/doi.org\/10.1258\/om.2011.110013.","journal-title":"Obstet Med."},{"issue":"3","key":"901_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1744-4667.2012.00113.x","volume":"14","author":"M Cauldwell","year":"2012","unstructured":"Cauldwell M, Nelson-Piercy C. Maternal and fetal complications of systemic lupus erythematosus. Obstet Gynaecol. 2012;14(3):167\u201374. https:\/\/doi.org\/10.1111\/j.1744-4667.2012.00113.x.","journal-title":"Obstet Gynaecol."},{"issue":"suppl_5","key":"901_CR59","doi-asserted-by":"publisher","first-page":"v9","DOI":"10.1093\/rheumatology\/key141","volume":"57","author":"MEB Clowse","year":"2018","unstructured":"Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E, et al. The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. Rheumatology. 2018;57(suppl_5):v9\u2013v17. https:\/\/doi.org\/10.1093\/rheumatology\/key141.","journal-title":"Rheumatology."},{"issue":"2","key":"901_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/GCO.0000000000000528","volume":"31","author":"SC Do","year":"2019","unstructured":"Do SC, Druzin ML. Systemic lupus erythematosus in pregnancy: high risk, high reward. Curr Opin Obstet Gynecol. 2019;31(2):120\u20136. https:\/\/doi.org\/10.1097\/GCO.0000000000000528.","journal-title":"Curr Opin Obstet Gynecol."},{"issue":"8","key":"901_CR61","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10067-016-3323-9","volume":"35","author":"S Upala","year":"2016","unstructured":"Upala S, Yong WC, Sanguankeo A. Association between primary Sj\u00f6gren\u2019s syndrome and pregnancy complications: a systematic review and meta-analysis. Clin Rheumatol. 2016;35(8):1949\u201355. https:\/\/doi.org\/10.1007\/s10067-016-3323-9.","journal-title":"Clin Rheumatol."},{"key":"901_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bpobgyn.2019.10.001","volume":"64","author":"E Arslan","year":"2020","unstructured":"Arslan E, Branch DW. Antiphospholipid syndrome: diagnosis and management in the obstetric patient. Best Pract Res Clin Obstet Gynaecol. 2020;64:31\u201340. https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.10.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"901_CR63","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0049-3848(19)30366-4","volume":"181","author":"K Schreiber","year":"2019","unstructured":"Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thromb Res. 2019;181:S41\u20136. https:\/\/doi.org\/10.1016\/S0049-3848(19)30366-4.","journal-title":"Thromb Res."},{"issue":"2","key":"901_CR64","first-page":"41","volume":"5","author":"FAF Di Prima","year":"2011","unstructured":"Di Prima FAF, Valenti O, Hyseni E, Giorgio E, Faraci M, Renda E, De Domenico R, Monte S. Antiphospholipid syndrome during pregnancy: the state of the art. J Prenat Med. 2011;5(2):41\u201353.","journal-title":"J Prenat Med."},{"issue":"5","key":"901_CR65","doi-asserted-by":"publisher","first-page":"525.e1","DOI":"10.1016\/j.ajog.2017.01.026","volume":"216","author":"G Saccone","year":"2017","unstructured":"Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017;216(5):525.e1\u2013525.e12. https:\/\/doi.org\/10.1016\/j.ajog.2017.01.026.","journal-title":"Am J Obstet Gynecol."},{"key":"901_CR66","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1358\/dnp.2009.22.9.1437961","volume":"22","author":"MK Santillan","year":"2009","unstructured":"Santillan MK, Santillan DA, Sigmund CD, Hunter SK. From molecules to medicine: a future cure for preeclampsia. Drug News Perspect. 2009;22:531\u201341.","journal-title":"Drug News Perspect."},{"issue":"11","key":"901_CR67","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1701-2163(16)32656-1","volume":"29","author":"A Kazmin","year":"2007","unstructured":"Kazmin A, Garcia-Bournissen F, Koren G. Risk of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can. 2007;29(11):906.","journal-title":"J Obstet Gynaecol Can."},{"issue":"6","key":"901_CR68","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3899\/jrheum.181460","volume":"47","author":"J Blagojevic","year":"2020","unstructured":"Blagojevic J, AlOdhaibi KA, Aly AM, Bellando-Randone S, Lepri G, Bruni C, et al. Pregnancy in systemic sclerosis: results of a systematic review and metaanalysis. J Rheumatol. 2020;47(6):881\u20137. https:\/\/doi.org\/10.3899\/jrheum.181460.","journal-title":"J Rheumatol."},{"issue":"3","key":"901_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1753495X19878042","volume":"13","author":"KE Clark","year":"2020","unstructured":"Clark KE, Etomi O, Ong VH. Systemic sclerosis in pregnancy. Obstet Med. 2020;13(3):105\u201311. https:\/\/doi.org\/10.1177\/1753495X19878042.","journal-title":"Obstet Med."},{"issue":"11","key":"901_CR70","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/1744666X.2016.1194201","volume":"12","author":"V Sobanski","year":"2016","unstructured":"Sobanski V, Launay D, Depret S, Ducloy-Bouthors A-S, Hachulla E. Special considerations in pregnant systemic sclerosis patients. Expert Rev Clin Immunol. 2016;12(11):1161\u201373. https:\/\/doi.org\/10.1080\/1744666X.2016.1194201.","journal-title":"Expert Rev Clin Immunol."},{"issue":"8","key":"901_CR71","first-page":"473","volume":"19","author":"P Triggianese","year":"2017","unstructured":"Triggianese P, Conigliaro P, Chimenti MS, Barbato C, Greco E, Kroegler B, De Carolis C, Perricone R. Systemic sclerosis: exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort. IMAJ. 2017;19(8):473\u20137 PMID: 28825764.","journal-title":"IMAJ"},{"key":"901_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jri.2016.02.004","volume":"114","author":"F Beneventi","year":"2016","unstructured":"Beneventi F, Locatelli E, Caporali R, Alpini C, Lovati E, Ramoni V, et al. Connective tissue diseases and autoimmune thyroid disorders in the first trimester of pregnancy. J Reprod Immunol. 2016;114:32\u20137. https:\/\/doi.org\/10.1016\/j.jri.2016.02.004.","journal-title":"J Reprod Immunol."},{"issue":"3","key":"901_CR73","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.clindermatol.2016.02.006","volume":"34","author":"J Wan","year":"2016","unstructured":"Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum. Clin Dermatol. 2016;34(3):344\u201352. https:\/\/doi.org\/10.1016\/j.clindermatol.2016.02.006.","journal-title":"Clin Dermatol."},{"issue":"1","key":"901_CR74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1874312901409010036","volume":"9","author":"P Sandhya","year":"2015","unstructured":"Sandhya P, Jeyaseelan L, Scofield RH, Danda D. Clinical characteristics and outcome of primary Sjogren\u2019s syndrome: a large Asian Indian cohort. Open Rheumatol J. 2015;9(1):36\u201345. https:\/\/doi.org\/10.2174\/1874312901409010036.","journal-title":"Open Rheumatol J."},{"issue":"9","key":"901_CR75","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/rheumatology\/ker077","volume":"50","author":"SZ Hussein","year":"2011","unstructured":"Hussein SZ, Jacobsson LT, Lindquist PG, Theander E. Pregnancy and fetal outcome in women with primary Sjogren\u2019s syndrome compared with women in the general population: a nested case-control study. Rheumatology (Oxford). 2011 Sep;50(9):1612\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/ker077.","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"901_CR76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.autrev.2013.09.003","volume":"13","author":"S De Carolis","year":"2014","unstructured":"De Carolis S, Salvi S, Botta A, Garofalo S, Garufib K, Ferrazzani S, De Carolis MP. The impact of primary Sjogren\u2019s syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev. 2014;13(2):103\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2013.09.003.","journal-title":"Autoimmun Rev."},{"issue":"6","key":"901_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1515\/jpm-2019-0034","volume":"47","author":"B Elliott","year":"2019","unstructured":"Elliott B, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Effect of Sj\u00f6gren\u2019s syndrome on maternal and neonatal outcomes of pregnancy. J Perinat Med. 2019;47(6):637\u201342. https:\/\/doi.org\/10.1515\/jpm-2019-0034.","journal-title":"J Perinat Med."},{"key":"901_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.reprotox.2008.10.007","volume":"27","author":"V Alonso","year":"2009","unstructured":"Alonso V, Linares V, Bell\u00e9s M, Albina ML, Sirvent JJ, Domingo JL, S\u00e1nchez DJ. Sulfasalazine induced oxidative stress: a possible mechanism of male infertility. Reprod Toxicol. 2009;27:35\u201340.","journal-title":"Reprod Toxicol."},{"key":"901_CR79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/14740338.2011.529898","volume":"10","author":"V Linares","year":"2011","unstructured":"Linares V, Alonso V, Domingo JL. Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Expert Opin Drug Saf. 2011;10:253\u201363.","journal-title":"Expert Opin Drug Saf."},{"issue":"4","key":"901_CR80","doi-asserted-by":"publisher","first-page":"E715","DOI":"10.1073\/pnas.1715035115","volume":"115","author":"DM Kristensen","year":"2018","unstructured":"Kristensen DM, Desdoits-Lethimonier C, Mackey AL, Dalgaard MD, De Masi F, Munkb\u00f8l CH, et al. Ibuprofen alters human testicular physiology to produce a state of compensated hypogonadism. Proc Natl Acad Sci U S A. 2018;115(4):E715\u201324.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"901_CR81","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/humrep\/det112","volume":"28","author":"O Albert","year":"2013","unstructured":"Albert O, Desdoits-Lethimonier C, Lesn\u00e9 L, Legrand A, Guill\u00e9 F, Bensalah K, Dejucq-Rainsford N, J\u00e9gou B. Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro. Hum Reprod. 2013;28(7):1890\u20138.","journal-title":"Hum Reprod."},{"key":"901_CR82","first-page":"365","volume":"71","author":"S Perrier d\u2019Hauterive","year":"2012","unstructured":"Perrier d\u2019Hauterive S, Kesseler S, Ruggeri P, Timmermans M, Gaspard O, Kumke T, Parker G. Certolizumab PEGOL did not result in a decrease in semen quality in healthy volunteers: results from a phase 1 study. Ann Rheum Dis. 2012;71:365\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"901_CR83","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/rheumatology\/keu007","volume":"53","author":"MC Micu","year":"2014","unstructured":"Micu MC, Micu R, Surd S, G\u00eerlovanu M, Bolboac\u0103 SD, Ostensen M. TNF-\u03b1 inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment. Rheumatology (Oxford). 2014;53(7):1250\u20135.","journal-title":"Rheumatology (Oxford)."},{"issue":"11","key":"901_CR84","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1111\/jdv.14364","volume":"31","author":"F Heppt","year":"2017","unstructured":"Heppt F, Colsman A, Maronna A, Uslu U, Heppt MV, Kiesewetter F, Sticherling M. Influence of TNF-alpha inhibitors and fumaric acid esters on male fertility in psoriasis patients. J Eur Acad Dermatol Venereol. 2017;31(11):1860\u20136.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"901_CR85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/bcpt.12857","volume":"122","author":"MD Larsen","year":"2018","unstructured":"Larsen MD, Friedman S, Magnussen B, N\u00f8rg\u00e5rd BM. Birth outcome of children fathered by men treated with systemic corticosteroids during the conception period - a cohort study based on nationwide data. Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):133\u20138.","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"4","key":"901_CR86","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.MIB.0000164023.10848.c4","volume":"11","author":"U Mahadevan","year":"2005","unstructured":"Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(4):395\u20139.","journal-title":"Inflamm Bowel Dis."}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-00901-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T12:38:09Z","timestamp":1672749489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-00901-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-00901-6","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (this article does not contain any studies with human participants or animals performed by any of the authors).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}